What Survodutide is
Survodutide is glp-1 / glucagon dual agonist. metabolic research. It sits within metabolic research (appetite, glycemic control, body composition). Pepture keeps Survodutide in the library as a tracking target only, the app records what you enter but makes no recommendation about whether the compound is appropriate for you. That decision belongs with a licensed clinician.
Published pharmacokinetic data places the half-life of Survodutide at roughly 5.41667 days, and doses recorded in the community cluster around the 1.8 mg to 3.6 mg range. Individual protocols vary widely. Jurisdictional status (FDA-approved, prescription, or research only) depends on the specific formulation and country.
How people track Survodutide
In Pepture, Survodutide is typically logged alongside fasted weight, waist, appetite score, fasting glucose, so cycle impact can be reviewed at the end of a block rather than by memory. The app captures dose, site, reconstitution ratio, cycle day, and any subjective rating you choose to add.
If you are considering Survodutide but have not started, or if you have started and want a second opinion, speak with a licensed clinician before changing any dose or cycle pattern.
Reconstitution math
Open the pre-filled Survodutide reconstitution calculator to compute syringe units per dose.
Reported Side Effects of Survodutide
Effects below are summarised from peer-reviewed literature or regulatory labeling where it exists. Not medical advice. Individual responses vary.
- Nausea, vomiting, and diarrhea, especially during dose titration DailyMed
- Constipation and early satiety DailyMed
- Injection-site reactions including redness and induration FDA label
- Gallbladder-related events (cholelithiasis, cholecystitis) reported in pivotal trials NEJM
- Risk of pancreatitis (discontinue if suspected) FDA label
- Contraindicated in personal or family history of medullary thyroid carcinoma or MEN 2 FDA boxed warning
Compare Survodutide
How Survodutide stacks up against the peers most users consider.